Monthly Archives for February 2017

Adherium Limited (ASX : ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today announced the appointment of a new Vice President of.

James Hattersly, senior vice president of business development at smart inhaler and respiratory health management company Adherium, said that adage applies even in his organization, where clinical outcomes drive most.

Adherium to speak at the Digital and Personal Connected Health event February 19th and Monday, February 20th in Orlando, as part of HIMSS. Adherium will be part of a panel.

Melbourne, Australia, 10 February 2017, Adherium Limited (ASX: ADR, ‘Adherium’), a global leader in digital health technologies addressing sub-optimal medication use in chronic disease, welcomes the recommendations highlighted in Asthma.

As a lifelong asthma patient, Adherium CEO Garth Sutherland was excited to see his company’s Smartinhaler chosen for the myAirCoach program, part of the European Union’s Horizon 2020 Framework for.